Yunsheng He

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating ophthalmic disorders
- Patent number 11,725,246
- Issue date Aug 15, 2023
- Novartis AG
- Joy Ghosh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetyl...
- Patent number 11,359,241
- Issue date Jun 14, 2022
- Novartis AG
- Dominik Feuerbach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetyl...
- Patent number 9,828,642
- Issue date Nov 28, 2017
- Novartis AG
- Dominik Feuerbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BIOMARKER PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYLC...
- Publication number 20220316011
- Publication date Oct 6, 2022
- Novartis AG
- Dominik Feuerbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING OPHTHALMIC DISORDERS
- Publication number 20210047692
- Publication date Feb 18, 2021
- Novartis AG
- Joy GHOSH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING DRY EYE DISEASE USING TNF ALPHA ANTAGONISTS
- Publication number 20190177407
- Publication date Jun 13, 2019
- Yunsheng He
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING OPHTHALMIC DISORDERS
- Publication number 20180230540
- Publication date Aug 16, 2018
- Joy GHOSH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYL...
- Publication number 20180037957
- Publication date Feb 8, 2018
- Novartis AG
- Dominik Feuerbach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMPACT OF GENETIC FACTORS ON DISEASE PROGRESSION AND RESPONSE TO AN...
- Publication number 20170073754
- Publication date Mar 16, 2017
- Novartis AG
- Yunsheng HE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYL...
- Publication number 20150275303
- Publication date Oct 1, 2015
- Novartis AG
- Dominik Feuerbach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS)
- Publication number 20130052644
- Publication date Feb 28, 2013
- Baltazar Gomez-Mancilla
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BioMarkers for the Progression of Alzheimer's Disease
- Publication number 20100035251
- Publication date Feb 11, 2010
- Yunsheng He
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BIOMARKERS FOR THE PREDICTION OF RESPONSIVENESS TO CLOZAPINE TREATMENT
- Publication number 20090281090
- Publication date Nov 12, 2009
- Novartis AG
- Yunsheng He
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Yunsheng He

Person

Patents Grantslast 30 patents

Methods of treating ophthalmic disorders

Biomarkers predictive of responsiveness to alpha 7 nicotinic acetyl...

Biomarkers predictive of responsiveness to alpha 7 nicotinic acetyl...

Patents Applicationslast 30 patents

BIOMARKER PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYLC...

METHODS OF TREATING OPHTHALMIC DISORDERS

METHODS OF TREATING DRY EYE DISEASE USING TNF ALPHA ANTAGONISTS

METHODS OF TREATING OPHTHALMIC DISORDERS

BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYL...

IMPACT OF GENETIC FACTORS ON DISEASE PROGRESSION AND RESPONSE TO AN...

BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYL...

Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS)

BioMarkers for the Progression of Alzheimer's Disease

BIOMARKERS FOR THE PREDICTION OF RESPONSIVENESS TO CLOZAPINE TREATMENT